These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 11888575)

  • 21. (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: clinical studies.
    McCann UD; Eligulashvili V; Ricaurte GA
    Neuropsychobiology; 2000; 42(1):11-6. PubMed ID: 10867551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugs.
    Halpern JH; Sherwood AR; Hudson JI; Gruber S; Kozin D; Pope HG
    Addiction; 2011 Apr; 106(4):777-86. PubMed ID: 21205042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studies.
    Vegting Y; Reneman L; Booij J
    Psychopharmacology (Berl); 2016 Oct; 233(19-20):3473-501. PubMed ID: 27568200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary evidence of hippocampal damage in chronic users of ecstasy.
    den Hollander B; Schouw M; Groot P; Huisman H; Caan M; Barkhof F; Reneman L
    J Neurol Neurosurg Psychiatry; 2012 Jan; 83(1):83-5. PubMed ID: 21444322
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary on Halpern et al. (2011): strengthening the case against functionally significant serotonergic neurotoxicity in human MDMA (ecstasy) users.
    Lyvers M
    Addiction; 2011 Apr; 106(4):787-8. PubMed ID: 21371152
    [No Abstract]   [Full Text] [Related]  

  • 27. [3,4-methylenedioxymethamphetamine ('ecstasy'): its long-term emotional and cognitive effects, and serotonin depletion].
    Molero-Chamizo A
    Rev Neurol; 2005 Jul 16-31; 41(2):108-14. PubMed ID: 16028190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hippocampal 1H-MRSI in ecstasy users.
    Obergriesser T; Ende G; Braus DF; Henn FA
    Eur Arch Psychiatry Clin Neurosci; 2001 Jun; 251(3):114-6. PubMed ID: 11697571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensity dependence of auditory evoked dipole source activity in polydrug ecstasy users: evidence from an 18 months longitudinal study.
    Daumann J; Till B; Fischermann T; Rezk M; Gouzoulis-Mayfrank E
    J Psychopharmacol; 2006 Mar; 20(2):236-44. PubMed ID: 16510481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ecstasy is a dangerous drug the society chooses to ignore].
    Heilig M
    Lakartidningen; 2003 Feb; 100(9):688-90. PubMed ID: 12674555
    [No Abstract]   [Full Text] [Related]  

  • 31. Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.
    Morgan MJ; Impallomeni LC; Pirona A; Rogers RD
    Neuropsychopharmacology; 2006 Jul; 31(7):1562-73. PubMed ID: 16292322
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is recreational ecstasy (MDMA) use associated with higher levels of depressive symptoms?
    Guillot C
    J Psychoactive Drugs; 2007 Mar; 39(1):31-9. PubMed ID: 17523583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
    de Win MM; Reneman L; Reitsma JB; den Heeten GJ; Booij J; van den Brink W
    Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Chang L; Ernst T; Grob CS; Poland RE
    J Magn Reson Imaging; 1999 Oct; 10(4):521-6. PubMed ID: 10508318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study.
    de Sola Llopis S; Miguelez-Pan M; Peña-Casanova J; Poudevida S; Farré M; Pacifici R; Böhm P; Abanades S; Verdejo García A; Langohr K; Zuccaro P; de la Torre R
    J Psychopharmacol; 2008 Jul; 22(5):498-510. PubMed ID: 18208910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered response to tryptophan supplementation after long-term abstention from MDMA (ecstasy) is highly correlated with human memory function.
    Curran HV; Verheyden SL
    Psychopharmacology (Berl); 2003 Aug; 169(1):91-103. PubMed ID: 12759801
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.
    de Win MM; Jager G; Booij J; Reneman L; Schilt T; Lavini C; Olabarriaga SD; den Heeten GJ; van den Brink W
    Brain; 2008 Nov; 131(Pt 11):2936-45. PubMed ID: 18842607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.